PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
06 2019
Historique:
received: 30 06 2018
revised: 31 10 2018
accepted: 15 11 2018
pubmed: 2 3 2019
medline: 15 9 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

Brain lesions in Alzheimer's disease (AD) include amyloid plaques made of Aβ peptides and neurofibrillary tangles composed of hyperphosphorylated tau protein with synaptic and neuronal loss and neuroinflammation. Aβ oligomers can trigger tau phosphorylation and neuronal alterations through activation of neuronal kinases leading to progressive cognitive decline. PKR is a ubiquitous pro-apoptotic serine/threonine kinase, and levels of activated PKR are increased in AD brains and AD CSF. In addition, PKR regulates negatively memory formation in mice. To assess the role of PKR in an AD in vivo model, we crossed 5xFAD transgenic mice with PKR knockout (PKRKO) mice and we explored the contribution of PKR on cognition and brain lesions in the 5xFAD mouse model of AD as well as in neuron-microglia co-cultures exposed to the innate immunity activator lipopolysaccharide (LPS). Nine-month-old double-mutant mice revealed significantly improved memory consolidation with the new object location test, starmaze test, and elevated plus maze test as compared to 5xFAD mice. Brain amyloid accumulation and BACE1 levels were statistically decreased in double-mutant mice. Apoptosis, neurodegeneration markers, and synaptic alterations were significantly reduced in double-mutant mice as well as neuroinflammation markers such as microglial load and brain cytokine levels. Using cocultures, we found that PKR in neurons was essential for LPS microglia-induced neuronal death. Our results demonstrate the clear involvement of PKR in abnormal spatial memory and brain lesions in the 5xFAD model and underline its interest as a target for neuroprotection in AD.

Identifiants

pubmed: 30821420
doi: 10.1111/acel.12887
pmc: PMC6516179
doi:

Substances chimiques

EIF2AK2 protein, human EC 2.7.11.1
eIF-2 Kinase EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12887

Subventions

Organisme : Agence Nationale de le Recherche France
ID : Malz 2013 NeurobioPKR
Pays : International

Informations de copyright

© 2019 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.

Références

Acta Neuropathol. 2009 Jul;118(1):5-36
pubmed: 19381658
J Biol Chem. 2018 Nov 30;293(48):18434-18443
pubmed: 30315100
Neurochem Int. 2014 Jan;64:73-83
pubmed: 24211709
EMBO Mol Med. 2016 Jun 01;8(6):595-608
pubmed: 27025652
EMBO J. 1995 Dec 15;14(24):6095-106
pubmed: 8557029
FASEB J. 2014 May;28(5):1965-74
pubmed: 24522206
Biol Psychiatry. 2012 May 1;71(9):829-35
pubmed: 22281122
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3729-36
pubmed: 17652745
PLoS One. 2013;8(1):e53587
pubmed: 23320095
Biochim Biophys Acta. 2012 Jun;1822(6):885-96
pubmed: 22306812
Brain. 2017 Jun 1;140(6):1544-1547
pubmed: 28549133
Neuroreport. 2002 Dec 20;13(18):2429-32
pubmed: 12499843
Alzheimers Res Ther. 2017 Oct 5;9(1):83
pubmed: 28982375
EMBO J. 1998 Aug 3;17(15):4379-90
pubmed: 9687506
Sci Signal. 2012 Oct 23;5(247):pe47
pubmed: 23092889
Mol Cell Biol. 2000 Jul;20(13):4532-42
pubmed: 10848580
Cell Death Dis. 2015 Jan 15;6:e1594
pubmed: 25590804
PLoS One. 2011;6(6):e21456
pubmed: 21738672
Brain Pathol. 2011 Mar;21(2):189-200
pubmed: 21029237
Neurobiol Aging. 2012 Jan;33(1):196.e29-40
pubmed: 20619937
Mol Cell. 2003 Mar;11(3):619-33
pubmed: 12667446
J Neurochem. 2002 Dec;83(5):1215-25
pubmed: 12437593
Exp Brain Res. 1997 Mar;113(3):509-19
pubmed: 9108217
J Neurosci. 2006 Oct 4;26(40):10129-40
pubmed: 17021169
J Neurosci. 2010 Feb 17;30(7):2582-94
pubmed: 20164343
Lancet Neurol. 2011 May;10(5):424-35
pubmed: 21481640
Acta Neuropathol. 2015 Sep;130(3):315-31
pubmed: 26210990
J Biol Chem. 2003 Dec 12;278(50):49819-27
pubmed: 12975376
J Neurochem. 2005 Feb;92(3):628-36
pubmed: 15659232
Cell. 2011 Dec 9;147(6):1384-96
pubmed: 22153080
Viruses. 2012 Oct 29;4(11):2598-635
pubmed: 23202496
Neuroscience. 2006;139(4):1343-54
pubmed: 16581193
Aging Cell. 2019 Jun;18(3):e12887
pubmed: 30821420
Lancet. 2016 Jul 30;388(10043):505-17
pubmed: 26921134
Neurobiol Learn Mem. 2008 Mar;89(3):260-8
pubmed: 17997332
Sci Rep. 2015 Feb 17;5:8489
pubmed: 25687824
Brain Pathol. 2012 Mar;22(2):219-29
pubmed: 21790829
J Neurosci. 2006 Apr 12;26(15):4071-81
pubmed: 16611824

Auteurs

Marion Tible (M)

Inserm U1144, Paris, France.

François Mouton Liger (F)

Inserm U1144, Paris, France.
Inserm U1127, Paris, France.

Julien Schmitt (J)

Institut de Biologie Paris Seine, CNRS, UMR 8246, Paris, France.
Inserm U1130, Paris, France.
Sorbonne Université, Paris, France.

Albert Giralt (A)

Sorbonne Université, Paris, France.
Inserm U839, Paris, France.
Institut du Fer à Moulin, Paris, France.

Karim Farid (K)

Department of Nuclear Medicine, CHU Fort de France, Martinique, France.
Center of Cognitive Neurology, Lariboisière Fernand Widal Hospital, APHP, Paris, France.

Sylvie Thomasseau (S)

Inserm U1144, Paris, France.

Sarah Gourmaud (S)

Inserm U1144, Paris, France.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Claire Paquet (C)

Inserm U1144, Paris, France.
Center of Cognitive Neurology, Lariboisière Fernand Widal Hospital, APHP, Paris, France.
Paris Diderot University, Paris, France.

Laure Rondi Reig (L)

Institut de Biologie Paris Seine, CNRS, UMR 8246, Paris, France.
Inserm U1130, Paris, France.
Sorbonne Université, Paris, France.

Eliane Meurs (E)

Hepacivirus and Innate Immunity Unit, Institut Pasteur, Paris, France.
CNRS, UMR 3569, Paris, France.

Jean-Antoine Girault (JA)

Sorbonne Université, Paris, France.
Inserm U839, Paris, France.
Institut du Fer à Moulin, Paris, France.

Jacques Hugon (J)

Inserm U1144, Paris, France.
Center of Cognitive Neurology, Lariboisière Fernand Widal Hospital, APHP, Paris, France.
Paris Diderot University, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH